Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial.

    ... and severe thrombocytopenia. Patients with a stable platelet count of lower than 30 × 109 platelets per L, aged at least ... endpoints were the proportion of patients achieving a platelet response within 24 weeks and safety. The interim analysis presented ...

    Research Article last updated 02/21/2017 - 9:49am.

  2. Transplant saves student who thought she had mono

    ... to get home for the holidays. I chalked the mono and low platelet count up to being super-stressed, and made an appointment to see ...

    Article last updated 03/06/2017 - 2:37pm.

  3. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes

    ... transfusion independence and 7 of 18 attained platelet transfusion independence. Most common grade 3-4 treatment-emergent ...

    Research Article last updated 02/03/2017 - 10:05am.

  4. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia

    ... (ANC) > 0.5×109/L, and the average time of 15.0d for platelet count was more than 20×109/L. Follow-up for 1 month later ...

    Research Article last updated 02/03/2017 - 9:36am.

  5. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results

    ... engraftment was 12 days (range 8-21 days) and for platelet engraftment was 19 days (range 8-154 days). The incidence was ...

    Research Article last updated 02/01/2017 - 12:30pm.

  6. Strong results for SAA patients at Johns Hopkins

    ... of the patients' red and white blood cell and platelet counts had returned to normal levels without the need for blood ...

    Article last updated 02/07/2017 - 11:05am.

  7. Mary Swift

    ... with a rare blood disorder. I was bruising easily, and my  platelet  count was dangerously low. I was diagnosed to have ITP, had my ...

    Patient Chronicle last updated 03/01/2017 - 11:56am.

  8. Keith McCrae, MD

    ... have analyzed the levels of circulating endothelial cell, platelet , monocyte , and red blood cell -derived microparticles and ... patients compared to normal controls. The endothelial cell, platelet, and monocyte-derived microparticle levels do not appear significantly ...

    Grant Recipient last updated 02/27/2017 - 7:05am.

  9. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia

    ... was 25 (range, 2 to 58) days, and to last platelet transfusion to keep platelets counts over 50 × 103/mm3 was ...

    Research Article last updated 01/24/2017 - 10:04am.

  10. A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation

    ... study. Subjects must have ECOG PS of 0 to 2. Platelet count ≥20,000/µL (Transfusions to achieve this level are ...

    Clinical Trial last updated 02/22/2017 - 11:21am.